日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry Study

额颞叶变性的发病率和生存率:基于人群的登记研究

Nagel, Gabriele; Peter, Raphael Simon; Uzelac, Zeljko; Wernecke, Deborah; Niehaus, Ludwig; Trottenberg, Thomas; Jöbges, Michael; Dettmers, Christian; Bäzner, Hansjörg; Börtlein, Andreas; Althaus, Katharina; Mayer-Freitag, Kristina; Ratzka, Peter; Naumann, Markus; Lindner, Alfred; Chatzikonstantinou, Anastasios; Andres, Frank; Arnold, Guy; Blickhan, Marko; Opherk, Christian; Knier, Benjamin; Ertl, Michael; Metrikat, Jens; Huber, Roman; Thomas, Christine; Kozian, Ralf; Kimmig, Hubert; Demuth, Klaus; Hecht, Martin; Foerch, Christian; Kloetsch, Christof; Reinhard, Matthias; Bengel, Dietmar; Neuhaus, Oliver; Buttmann, Mathias; Volkmann, Jens; Pinkhardt, Elmar; Lichy, Christoph; Laske, Christoph; Beattie, James; Häckert, Jan; Jesse, Sarah; Brenner, David; Weishaupt, Jochen; Otto, Markus; Uttner, Ingo; Anderl-Straub, Sarah; Lulé, Dorothée E; Rothenbacher, Dietrich; Rosenbohm, Angela; Ludolph, Albert Christian

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

CONFIDENCE 治疗成功:德国奥克瑞珠单抗的长期真实世界疗效和安全性

Buttmann, Mathias; Weber, Martin S; Meuth, Sven G; Blümich, Sandra; Hieke-Schulz, Stefanie; Dirks, Petra; Eggebrecht, Julius C; Ziemssen, Tjalf

The Rising Incidence of Early-Onset Colorectal Cancer

早发性结直肠癌发病率上升

Tanaka, Luana Fiengo; Figueroa, Sieglinde Hechenbichler; Popova, Vera; Klug, Stefanie J; Buttmann-Schweiger, Nina

OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany

OzEAN 研究旨在收集德国复发缓解型多发性硬化症患者使用 Ozanimod 超过 5 年的真实世界证据,以评估其持续使用、疗效和安全性。

Ziemssen, Tjalf; Richter, Stephan; Mäurer, Mathias; Buttmann, Mathias; Kreusel, Boris; Poehler, Anne-Maria; Lampl, Maren; Linker, Ralf A

Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study

在真实世界中接受奥瑞珠单抗治疗的德国多发性硬化症患者队列中,安全性、依从性和持续性:CONFIDENCE 研究的初步见解

Weber, Martin S; Buttmann, Mathias; Meuth, Sven G; Dirks, Petra; Muros-Le Rouzic, Erwan; Eggebrecht, Julius C; Hieke-Schulz, Stefanie; Leemhuis, Jost; Ziemssen, Tjalf

Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity

NFATc1 SUMO化缺失可预防自身免疫和同种反应

Yin Xiao, Musga Qureischi, Lena Dietz, Martin Vaeth, Subrahmanya D Vallabhapurapu, Stefan Klein-Hessling, Matthias Klein, Chunguang Liang, Anika König, Edgar Serfling, Anja Mottok, Tobias Bopp, Andreas Rosenwald, Mathias Buttmann, Ingolf Berberich, Andreas Beilhack, Friederike Berberich-Siebelt

Inhibition of acid sphingomyelinase increases regulatory T cells in humans

抑制酸性鞘磷脂酶可增加人类调节性 T 细胞

Teresa Wiese, Fabio Dennstädt, Claudia Hollmann, Saskia Stonawski, Catherina Wurst, Julian Fink, Erika Gorte, Putri Mandasari, Katharina Domschke, Leif Hommers, Bernard Vanhove, Fabian Schumacher, Burkhard Kleuser, Jürgen Seibel, Jan Rohr, Mathias Buttmann, Andreas Menke, Jürgen Schneider-Schaulies,

Development of Incidence and Surgical Treatment of Penile Cancer in Germany from 2006 to 2016: Potential Implications for Future Management

2006年至2016年德国阴茎癌发病率和手术治疗的发展:对未来管理的潜在影响

Groeben, Christer; Koch, Rainer; Kraywinkel, Klaus; Buttmann-Schweiger, Nina; Baunacke, Martin; Borkowetz, Angelika; Thomas, Christian; Huber, Johannes

ASO Author Reflections: How Many Centers Do We Need for High-Quality Penile Cancer Surgery in Germany? An Analysis of Total Population Data from 2006 to 2016

ASO作者反思:德国需要多少个高质量阴茎癌手术中心?基于2006年至2016年总人口数据的分析

Groeben, Christer; Koch, Rainer; Kraywinkel, Klaus; Buttmann-Schweiger, Nina; Baunacke, Martin; Borkowetz, Angelika; Thomas, Christian; Huber, Johannes

[Seroprevalence of SARS-CoV-2 among children and adolescents in Germany-an overview]

[德国儿童和青少年SARS-CoV-2血清阳性率概述]

Thamm, Roma; Buttmann-Schweiger, Nina; Fiebig, Julia; Poethko-Müller, Christina; Prütz, Franziska; Sarganas, Giselle; Neuhauser, Hannelore